Study protocol for a randomised controlled trial evaluating the efficacy of a telehealth program - management of asthma with supportive telehealth of respiratory function in pregnancy (MASTERY ©)

AuthorsZairina, E.
Abramson, M. J.
McDonald, C. F.
Li, J.
Dharmasiri, T.
Stewart, K.
Walker, S.P.
Paul, E.
George, J.
TypeJournal Article (Original Research)
JournalBMC Pulmonary Medicine
PubMed ID4521452
Year of Publication2015
URLhttp://www.biomedcentral.com/1471-2466/15/84
DOIhttp://dx.doi.org/10.1186/s12890-015-0082-3
Download Zairina-2015-Study_protocol_for_a_randomised_c.pdf (1.1 MB)
AbstractBACKGROUND: Telehealth has the potential to improve asthma management through regular monitoring of lung function and/or asthma symptoms by health professionals in conjunction with feedback to patients. Although the benefits of telehealth for improving asthma management have been extensively studied, the feasibility of telehealth for supporting asthma management in pregnant women has not been investigated. This study aims to evaluate the use of telehealth for remotely monitoring lung function and optimising asthma control during pregnancy. METHODS: A randomised controlled trial comparing usual care with a telehealth program (MASTERY((c))) has been conducted. The intervention comprised a mobile application - Breathe-easy ((c)) supported by a Bluetooth-enabled handheld device (COPD-6(R)), which was used for self-monitoring of lung function (FEV1, FEV6) twice daily, and recording asthma symptoms and medication usage weekly; and a written asthma action plan (WAAP). The primary outcome measure is change in asthma control measured using the Asthma Control Questionnaire (ACQ). Secondary outcomes include changes in mini-Asthma Quality of Life Questionnaire (mAQLQ) score, lung function, asthma-related health visits, days off work/study, and oral corticosteroid use. Outcome data were collected at baseline, 3 months and 6 months by a research assistant masked to group allocation. Maternal and neonatal outcomes were also collected post-partum. DISCUSSION: This is the first study to evaluate the application of telehealth to optimize asthma management in pregnant women. If effective, this telehealth program could improve asthma self-management by pregnant women which may reduce the maternal and fetal risks of poorly controlled asthma during pregnancy.
TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ( ACTRN 12613000800729 ) 17 July 2013.

http://www.ibas.org.au/what-we-do/publications/3872812


< More publications



CHEST-MND:PROCHEST-MND:PRO

Motor neurone disease (MND) causes the body's muscles to weaken. Breathing muscle weakness means that most people affected by MND will eventually lose the ability to take a deep breath and cough strongly....

Respiratory Biomarkers in Motor Neurone DiseaseRESPIRATORY BIOMARKERS IN MOTOR NEURONE DISEASE

The inability to breathe is unfortunately the most common cause of death in people living with Motor Neurone Disease (MND). Last year, our clinical research group in Melbourne reported that breathing...

Recognising research meritRECOGNISING RESEARCH MERIT

Kudos to Dr. Lauren Booker & Dr. Jen Cori on their JOEM publication examining fatigue detection alarms in rural truck drivers. Their study explores the alarms' effectiveness, accuracy, and habituation, offering key insights into fatigue management.

Honoring Excellence in ResearchHONORING EXCELLENCE IN RESEARCH

Congratulations to Prof. Anne Holland and A/Prof. Narelle Cox for being featured in the NHMRC's 10 of the Best - 16th Edition. Their work exemplifies groundbreaking research delivering extraordinary outcomes.

World Sleep Day on 14th March 2025WORLD SLEEP DAY ON 14TH MARCH 2025

The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 14th March 2025.

AMRF Grant Awards for 2025AMRF GRANT AWARDS FOR 2025

Grants Success: The Institute for Breathing and Sleep (IBAS) has received two research grants from the Austin Medical Research Foundation (AMRF) for 2025. Congratulations to Dr Charissa Zaga and Dr Catherine Hill from IBAS.

Institute for Breathing and Sleep

Level 5, Harold Stokes Building, Austin Health
145 Studley Road
Heidelberg, Victoria, 3084

(03) 9496 5390

Email Us

Donate